Eric Adams
Patrimonio netto: 2 988 $ in data 30/09/2026
Patrimonio netto: 2 988 $ in data 30/09/2026
Mr. Eric A. Adams is a President, Chief Executive Officer & Director at InMed Pharmaceuticals, Inc. He is on the Board of Directors at InMed Pharmaceuticals, Inc. Mr. Adams was previously employed as a Chief Executive Officer by Ronin8 Technologies Ltd., a Non-Executive Director by enGene, Inc., a Director-Oncology Marketing by QLT, Inc., a Senior Manager-Business Development by Abbott Laboratories, and a Country Manager by Fresenius SE.
He received his undergraduate degree from the University of Southern Indiana and a graduate degree from the University of South Carolina.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/12/2025 | 2.197 ( 0,04% ) | 2 988 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Amministratore Delegato | 16/06/2016 |
| Società | Posizione | Fine |
|---|---|---|
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Amministratore Delegato | 01/02/2015 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Amministratore Delegato | 01/07/2013 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Vendite & Marketing | 01/12/2002 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/1996 |
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01/06/1992 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Industrial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale